• The use of Conversational agents (CAs) in healthcare is an emerging field. (whiterose.ac.uk)
  • Given the criticality of many healthcare settings, ML and other component errors may result in CA failures and may cause adverse effects on patients. (whiterose.ac.uk)
  • These patients should be isolated at a healthcare facility, in a private room and continue to undergo appropriate clinical assessment and management while determining whether ebolavirus testing is indicated. (cdc.gov)
  • Patients in the U.S. healthcare system can quickly rack up big bills that push them into debt even if they have insurance. (wgntv.com)
  • The COVID-19 pandemic has forever changed the approach we take in healthcare settings to protect healthcare personnel, patients, and others from transmission of respiratory infections. (cdc.gov)
  • management of · In Sierra Leone, about half of all COVID-19 patients admitted to COVID-19 patients healthcare facilities received antibiotics. (who.int)
  • COVID-19 patients admitted to healthcare facilities in Sierra Leone. (who.int)
  • Data collection was performed by healthcare workers trained to read patient clinical files. (who.int)
  • Bergqvist J, Iderberg H, Mesterton J, Bengtsson N, Wettermark B, Henriksson R. Healthcare resource use, comorbidity, treatment and clinical outcomes for patients with primary intracranial tumors: a Swedish population-based register study. (janusinfo.se)
  • Schmidt-Mende K, Andersen M, Wettermark B, Hasselström J. Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines -A pragmatic open-label cluster randomized controlled trial in primary care. (janusinfo.se)
  • In this scenario, supportive treatment to raise hemoglobin levels and diminish symptoms from anemia, including erythropoiesis-stimulating agents (ESAs), may become necessary. (springermedizin.at)
  • Evans M, Carrero JJ, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander-Rössner B, Rotnitzky A, Sjölander A. Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients. (janusinfo.se)
  • This accelerated approval was based on efficacy data from patients enrolled in one of five open-label, multi-cohort trials, including KEYNOTE-158. (businesswire.com)
  • Appropriately powered randomised studies directly comparing biological agents are lacking, but for the average patient, the tumour necrosis factor alpha antagonist (anti-TNF) agents are thought to have efficacy that is relatively comparable to one another and perhaps to other biological therapies with different mechanisms of action. (bmj.com)
  • 1 , - , 4 Given efficacy that many consider relatively comparable, other considerations such as safety may be important in choosing among the biological agents for an individual patient. (bmj.com)
  • These findings support clinic protocols based on decitabine prior to chemotherapy to overcome resistance and improve therapeutic efficacy in AML patients. (oncotarget.com)
  • A review recently published in the Israel Medical Association Journal evaluated the published literature on whether treatment efficacy, once lost with a first anti-TNF treatment, could be regained in patients with AS when they switching to a second anti-TNF agent. (centerforbiosimilars.com)
  • Researchers say that, because methotrexate or other immunosuppressive drugs prescribed concurrently with biologics are known to reduce the production of antibodies in patients with rheumatoid arthritis, evaluating antidrug antibody levels in patients with AS experiencing loss of efficacy may help when making drug switching decisions. (centerforbiosimilars.com)
  • METHODS This first-in-human trial (ClinicalTrials.gov identifier: NCT02500407) evaluated the safety and tolerability and efficacy of mosunetuzumab in patients with R/R B-NHL and established the recommended phase II dose. (wustl.edu)
  • The goal of this study was to assess the clinical efficacy of DAB/IL2 in an expanded cohort of stage IV melanoma patients. (biomedcentral.com)
  • Although the study was not designed to assess clinical efficacy, we did observe the regression of melanoma metastases in 3 patients. (biomedcentral.com)
  • Data on the safety and efficacy of rivaroxaban in paediatric patients published in 2020 4 supported its use for childhood VTE management and led to its recent FDA approval for this indication 5 . (medthority.com)
  • KEYTRUDA is approved for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors that have progressed following prior treatment and who have no satisfactory alternative treatment options. (businesswire.com)
  • KEYNOTE-158 (ClinicalTrials.gov, NCT02628067 ) is an ongoing global, open-label, non-randomized, multi-cohort, multi-center, Phase 2 study evaluating KEYTRUDA in patients with multiple types of advanced solid tumors - including endometrial carcinoma - that have progressed on standard of care therapy. (businesswire.com)
  • Purpose: To determine the maximum tolerated dose and dose-limiting toxicity (DLT) of the novel anticancer agent, motexafin gadolinium (MGd), administered concurrently with radiation therapy (RT) in patients with locally advanced pancreatic or biliary tumors. (elsevierpure.com)
  • For this reason, regulatory bodies have issued warnings for their use in this patient population and patients with severe kidney impairment typically have an MRI without contrast enhancement, which reduces image quality and ability to detect and localize cancer tumors or metastases. (pharmasalmanac.com)
  • Ascelia Pharma's SPARKLE study aims to demonstrate that Orviglance improves the detection and visualization of focal liver lesions, including liver metastases and primary tumors, in patients with severe kidney impairment. (pharmasalmanac.com)
  • Orviglance (manganese chloride tetrahydrate) is a novel oral contrast agent for MR-imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with reduced kidney function. (pharmasalmanac.com)
  • Joint guidelines for the use of antimicrobial agents for prophylaxis and treatment in neutropenic cancer patients have been issued by the American Society of Clinical Oncology (ASCO) and the Infectious Diseases Society of America (IDSA). (medscape.com)
  • The aim of our study was to determine the proportion of "bad" responders to mitogen among patients with negative QFT and to discuss the clinical relevance of the 0.5 IU·mL −1 threshold for positive control. (ersjournals.com)
  • The medical records for these patients were reviewed, and their clinical and laboratory data were analyzed. (biomedcentral.com)
  • Furthermore, the National Swedish Biologics Registry has shown that the co-administration of conventional disease-modifying rheumatic drugs was associated with a 5-year retention of the first anti-TNF therapy in patients with a clinical diagnosis of AS or undifferentiated spondyloarthritis who started treatment with adalimumab, etanercept, or infliximab as their first anti-TNF drug between 2003 and 2010. (centerforbiosimilars.com)
  • In order to better define the clinical activity of DAB/IL2 against melanoma and provide rationale for randomized multi-center trials, we now have expanded this initial exploratory trial to include a total of 60 stage IV melanoma patients and will present herein the objective response rates and results of survival analyses. (biomedcentral.com)
  • We have succeeded in enrolling 80 patients in a rare disease clinical study under highly challenging circumstances, including a global pandemic and the invasion of Ukraine. (pharmasalmanac.com)
  • Based on strong results in earlier clinical studies, we are optimistic of a positive outcome of SPARKLE and look forward to the next steps in bringing Orviglance through the regulatory process and making it available to patients for whom the use of gadolinium-based products may be medically inadvisable", said Magnus Corfitzen. (pharmasalmanac.com)
  • This document provides guidance for hospitals and clinical laboratories on performing routine diagnostic (non-ebolavirus) testing necessary for management and care of patients with suspected ebolavirus infection, while minimizing risk to laboratory personnel. (cdc.gov)
  • If a hospital facility is unable to provide appropriate clinical care and laboratory diagnostic testing for a suspect case of Ebola disease, the patient should be transferred to a facility that is able to provide appropriate management until ebolavirus testing is completed. (cdc.gov)
  • Embodied conversational agents may take on a diversity of roles in learning and advisory scenarios including virtual teachers, advisors, learning companions, and autonomous actors in educational role play. (chatbots.org)
  • In this study, we investigated the effect of pre-treatment with demethylating agent decitabine on susceptibility to chemotherapeutic drugs in HL60/ADR, Kasumi-1 and primary AML cells. (oncotarget.com)
  • Immunosuppressive agents encompassed a large number of drugs, mainly represented by anti-tumour necrosis factor (TNF)-α, anti-retroviral therapy (ARV), azathioprine (AZT), methotrexate (MTX), mycophenolate mofetil (MMF), non-steroidal anti-inflammatory drugs (NSAIDs), rituximab and steroids. (ersjournals.com)
  • 9 Few other data exist with which to compare the anti-TNF biological agents with newer agents including abatacept and rituximab. (bmj.com)
  • Therapeutic approaches for the treatment of chemotherapy induced anemia encompass red blood cell (RBC) transfusions and erythropoietin-stimulating agents (ESAs). (springermedizin.at)
  • The latter are approved for the treatment of patients with symptomatic anemia caused by palliative chemotherapy to reduce the number of RBC transfusions and gradually improve anemia-related symptoms. (springermedizin.at)
  • In some patients with cancer, causes of anemia remain unclear or are inevitable (e.g., myelotoxic chemotherapy). (springermedizin.at)
  • This short review focuses on indications, advantages, and risks of ESAs in patients with chemotherapy-associated anemia that develops during treatment of nonhematologic malignancies. (springermedizin.at)
  • We discuss the current evidence of the correlation of Schlafen 11 expression in ovarian cancer with treatment outcomes and the potential use of Schlafen 11 as the key predictive and prognostic marker that could help to better stratify ovarian cancer patients treated with platinum-based chemotherapy or PARP inhibitors. (muni.cz)
  • Biological agents used for the treatment of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are associated with serious adverse effects (SAEs). (frontiersin.org)
  • We conducted a longitudinal study in PsA and RA patients only taking long-term biological agents from 2003 to 2011. (frontiersin.org)
  • Of the 268 patients, 116 (43.3%) experienced one or more adverse events related to biological agents with 1.6 events per patient, and of these 29 (25%) experienced one or more SAEs, with majority subjected to hospitalizations. (frontiersin.org)
  • The wide use of biological agents in modern medicine is a challenge for physicians and requires constant learning, with distinct knowledge and familiarity of the disease to be treated. (frontiersin.org)
  • Additionally, these biological agents are expensive and compel the physicians to consider the economic burden on patients. (frontiersin.org)
  • Background It is unclear whether anti-tumour necrosis factor alpha and biological agents with different mechanisms of action have similar safety. (bmj.com)
  • This study evaluated the incidence of hospitalised infections among rheumatoid arthritis (RA) patients starting or switching various biological agents. (bmj.com)
  • Proportional hazards models estimated the hazard ratio of hospitalised infections, comparing each biological agent with infliximab. (bmj.com)
  • Results Among 7847 biological treatment episodes, 63% were for biological-free patients and 37% for switchers. (bmj.com)
  • Patient risk factors contributed more to the risk of infection than did the risk associated with specific biological therapies. (bmj.com)
  • Most of the variability in patients' risk of infection was driven by factors other than biological agent exposure. (bmj.com)
  • Numerous factors contribute to the decision to choose biological agents for the treatment of rheumatoid arthritis (RA). (bmj.com)
  • One potentially confounding factor is that most patients receive these biological agents with non-tumour necrosis factor alpha mechanisms of action only after failing one or more anti-TNF therapies, consistent with some national guidelines. (bmj.com)
  • Biological warfare (BW) is the use of microbiological agents for hostile purposes. (msdmanuals.com)
  • Such use is contrary to international law and has rarely taken place during formal warfare in modern history, despite the extensive preparations and stockpiling of biological agents carried out during the 20th century by most major powers (including development of strains resistant to multiple drugs). (msdmanuals.com)
  • Biological-warfare agents are thought by some to be an ideal weapon for terrorists. (msdmanuals.com)
  • It can be difficult to distinguish use of a biological-warfare (BW) agent from a natural outbreak of disease. (msdmanuals.com)
  • Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association. (bepress.com)
  • Cohort K enrolled 79 patients with MSI-H endometrial carcinoma and Cohort D enrolled 11 patients with MSI-H endometrial carcinoma for a total of 90 pooled patients who received KEYTRUDA as monotherapy (200 mg fixed dose every three weeks). (businesswire.com)
  • A literature search was undertaken for evidence of the effect of succinylcholine (SCH) on the intracranial pressure (ICP) of patients with acute brain injury and whether pretreatment with a defasciculating dose of competitive neuromuscular blocker is beneficial in this patient group. (bmj.com)
  • We also present a case study of a CA used for calculating insulin dose for gestational diabetes mellitus (GDM) patients. (whiterose.ac.uk)
  • The following information includes only the average dose of sunscreen agents. (mayoclinic.org)
  • Single-agent mosunetuzumab was administered intravenously in 3-week cycles, at full dose in cycle 1 day 1 (group A) or with ascending (step-up) doses during cycle 1 on days 1, 8, and 15 (group B), for eight or 17 cycles on the basis of tumor response. (wustl.edu)
  • Results: Eight patients were treated at dose level 1 (2.9 mg/kg), with one DLT (grade 3 fever). (elsevierpure.com)
  • Three patients were treated at dose level 2 (3.6 mg/kg), and two DLTs were noted. (elsevierpure.com)
  • Conclusion The rate of hospitalised infections among RA patients was highest for infliximab. (bmj.com)
  • 5 , - , 8 A relatively small trial comparing abatacept and infliximab suggested safety-related differences between these two agents. (bmj.com)
  • One study found anti-drug antibodies in 25.9% of patients, 81.8% of which were found in the patients treated with infliximab, and 18.2% in patients treated with adalimumab. (centerforbiosimilars.com)
  • The purpose of this article is to discuss medication nonadherence and the use of relational agent technology as an aid in treating patients with schizophrenia. (chatbots.org)
  • Methods: Cohorts of three to six patients were treated with escalating doses of MGd, administered three times per week for a total of 16 doses concurrent with RT. (elsevierpure.com)
  • Antifungal prophylaxis with an oral triazole or parenteral echinocandin is recommended for patients who are at risk for profound, protracted neutropenia, such as most patients with acute myeloid leukemia/myelodysplastic syndromes or HSCT. (medscape.com)
  • We performed a prospective feasibility study in 21 patients with HMA-refractory MDS enrolled at Stanford University from April 2018 through March 2019. (notablelabs.com)
  • We demonstrated in clinic that combination of decitabine and HAA consisting of harringtonine, aclarubicin and cytarabine was effective and safe to treat patients with refractory, relapsed or high-risk AML. (oncotarget.com)
  • The safety and effectiveness of KEYTRUDA in pediatric patients with MSI-H central nervous system cancers have not been established. (businesswire.com)
  • Outcomes in Traumatic Brain Injury Patients on Preinjury Anticoagulation and Antiplatelet Agents" by Sandra Ho, BA, MHS, 4th year medical student, Vismay Thakkar, MBBS et al. (jefferson.edu)
  • Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction. (janusinfo.se)
  • The Danish database for biologic therapies, DANBIO, analyzed data from 432 patients who switched to a second, and 137 patients who switched to a third, anti-TNF drug. (centerforbiosimilars.com)
  • KEYTRUDA monotherapy is already playing a role for the treatment of certain patients with advanced endometrial carcinoma through the tumor-agnostic MSI-H indication which received accelerated approval four years ago. (businesswire.com)
  • KEYTRUDA was also granted accelerated approval in September 2019, and received full approval in July 2021, in combination with LENVIMA ® (lenvatinib) for the treatment of patients with advanced endometrial carcinoma that is not MSI-H or dMMR, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation. (businesswire.com)
  • Diana Do, MD, professor of ophthalmology at Stanford's Byers Eye Institute, presents research on a newly developed, novel patient-reported outcome instrument (PRO) for patients who have proliferative diabetic retinopathy and who are undergoing treatment with either intravitreal anti-VEGF therapy, or panretinal photocoagulation. (ophthalmologytimes.com)
  • I had the pleasure of presenting research that our team conducted looking at developing a novel patient reported outcome instrument for patients who have proliferative diabetic retinopathy and who are undergoing treatment with either intravitreal anti-VEGF therapy, or panretinal photocoagulation. (ophthalmologytimes.com)
  • We did an extensive literature review, then a round of interviews with both retina specialists and over 80 patients to understand their treatment experience. (ophthalmologytimes.com)
  • Thus, the latest guidelines from the European Association for the Study of Liver (EASL) recommend that for empirical treatment of SBP in cirrhotic patients with ascites, distinguishing nosocomial SBP from community-acquired SBP is necessary [ 11 ]. (biomedcentral.com)
  • Prehospital treatment is usually only indicated in hemodynamically unstable patients. (medscape.com)
  • Anti-tumor necrosis factor (anti-TNF) treatment has revolutionized the management of ankylosing spondylitis (AS), but 20% to 30% of patients discontinue treatment due to failure or inadequate response to treatment. (centerforbiosimilars.com)
  • In terms of retention and predictive factors, included in this review was a large study of 1250 patients with active AS, and of the total number of patients enrolled, 1159 (92.7%) completed 12 weeks of treatment with adalimumab. (centerforbiosimilars.com)
  • These data support the development of multi-center, randomized trials of DAB/IL2 as a monotherapy and in combination with other immunotherapeutic agents for the treatment of stage IV melanoma. (biomedcentral.com)
  • Comment from discussion Medical professionals of Reddit, what is the craziest DIY treatment you've seen a patient attempt? . (pedestrian.tv)
  • The direct oral anticoagulants (DOACs) apixaban and rivaroxaban , also known as direct oral factor Xa inhibitors (DXIs), are used for stroke prevention in adult patients with non-valvular heart disease, and treatment and prevention of venous thromboembolism (VTE) 1 . (medthority.com)
  • Flatt, PR & Conlon, JM 2018, ' Editorial: Newer peptide-based agents for treatment of patients with Type 2 diabetes ', Peptides , vol. 100, pp. 1-2. (ulster.ac.uk)
  • Since 1 March, 12 patients including women and children with respiratory symptoms and blistering have been received for treatment by a referral hospital in Erbil according to local health authorities. (who.int)
  • Forslund T, Wettermark B, Andersen M, Hjemdahl P. Stroke and bleeding with NOAC or warfarin treatment in patients with non-valvular atrial fibrillation: a population based cohort study. (janusinfo.se)
  • Loikas D, Forslund T, Wettermark B, Schenck-Gustafsson K, Hjemdahl P, von Euler M. Increased thromboprophylactic treatment in patients with atrial fibrillation after the introduction of NOACs - an analysis of sex and gender differences. (janusinfo.se)
  • The advent of the newer classes of antihyperglycemic agents, including SGLT2 (sodium glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists, has changed the landscape of therapeutic options for patients with CKD with T2D, with demonstration of significant reductions in cardiovascular adverse events and progression to end-stage kidney disease. (bepress.com)
  • This scientific statement summarizes the current literature on the cardiorenal protective effects with SGLT2 inhibitors and GLP-1 receptor agonists in patients with CKD and T2D. (bepress.com)
  • The new promising marker Schlafen 11 seems to correlate with sensitivity or resistance to DNA-damaging agents, including platinum compounds or PARP inhibitors in various types of cancer. (muni.cz)
  • From the patients' ascitic fluids, 334 pathogenic strains, including 178 Gram-negative bacterial strains, 138 Gram-positive bacterial strains and 18 other microbial strains were isolated. (biomedcentral.com)
  • The strains isolated from the patients with nosocomial SBP displayed higher drug resistance than those isolated from patients with community-acquired SBP. (biomedcentral.com)
  • Phylogenetic analysis indicates that the Finnish SINV strains are closely related to the viral agents isolated from mosquitoes and that cause clinically similar diseases in nearby geographic areas. (cdc.gov)
  • The causative agent of the disease has been suspected of being closely related to Sindbis virus (SINV). (cdc.gov)
  • The aim of this study was to isolate the causative agent of Pogosta disease directly from human samples. (cdc.gov)
  • The most frequently reported ADRs were administration site reactions as observed in 73 patients (27.2%), infections in 30 patients (11.2%), effects on nervous system in 22 patients (8.2%), and 15 (5.6%) patients withdrew due to ADRs. (frontiersin.org)
  • This report provides interim biosafety guidelines for preventing laboratory-associated infections with agents that cause hantavirus pulmonary syndrome. (cdc.gov)
  • In 2018, and 2019 andexanet alfa became the first agent to be approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), respectively, for the reversal of life-threatening or uncontrolled bleeding in patients receiving apixaban or rivaroxaban 3 . (medthority.com)
  • [ 3 ] In Western countries, the financial burden on patients ranges from $300 to $1,300 per patient year, increasing with more severe disease. (medscape.com)
  • Unstable patients are those with ongoing chest pain, severe shortness of breath, altered level of consciousness, or hypotension. (medscape.com)
  • more than half of all expenditures are attributed to the 10-20% of patients with the most severe disease. (medscape.com)
  • Of these, 4 patients are showing severe signs associated with exposure to a blister agent. (who.int)
  • The integration will be designed to allow health systems to leverage chatbots to match patients effectively with providers through automated routing and self-service appointment booking and management capabilities. (masstlc.org)
  • RATIONALE Latent tuberculosis (TB) infection screening before inducing anti- tumor necrosis factor (anti-TNF) alpha agents is important to prevent TB reactivation. (bvsalud.org)
  • abstract = "Enhanced access and continuity are key components of patient-centered care. (elsevierpure.com)
  • In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? (bmj.com)
  • Many patients who undergo cutaneous surgery take medications that can affect bleeding. (psu.edu)
  • It reviews potential mechanistic pathways that may drive these benefits and summarizes the literature on adverse effects in patients with CKD and T2D at risk for or with established cardiovascular disease. (bepress.com)
  • The quantification of adverse effects (serious or nonserious) considering close monitoring and patients' perceptions are increasingly important for future decision-making. (frontiersin.org)
  • All laboratories that handle patient specimens in the United States must always comply with this standard. (cdc.gov)
  • The guidelines address handling patient-derived specimens, propagating viruses in culture (including viral concentrate preparations), and housing and handling infected animals. (cdc.gov)
  • The liver is the second most likely organ for metastases to develop, playing a significant role in the demise of patients diagnosed with breast or colorectal cancer. (pharmasalmanac.com)
  • MRI is usually the preferred imaging modality for both initial cancer disease staging and monitoring of liver metastases and relies on contrast agents to improve the quality of the obtained scan. (pharmasalmanac.com)
  • 21 day cycles) was administered to 60 unresectable stage IV melanoma patients and response rates were assessed using a combination of 2-[ 18 F]-fluoro-2-deoxy-glucose (FDG)-positron emission tomography (PET) and computed tomography (CT) imaging. (biomedcentral.com)
  • Danish and Norwegian registries have provided data relating to patients with AS who switched to a different anti-TNF therapy. (centerforbiosimilars.com)
  • The review found that 30% of patients starting anti-TNF therapy switched to a second anti-TNF drug, and noted that there is no difference in drug survival between the first, second, or third anti-TNF therapy. (centerforbiosimilars.com)
  • There is a lack of evidence-based literature regarding the use of andexanet alfa or PCC therapy for DXI reversal in children, although these agents are currently used in children 8 . (medthority.com)
  • Anti- TNF-alpha agent with an immunomodulator was immediately discontinued, and anti-TB therapy was initiated. (bvsalud.org)
  • LESSONS This case report presented a patient in whom VDZ was continued as maintenance therapy without inducing TB relapse in a patient with CD who developed latent TB infection reactivation associated with anti- TNF-alpha agents and summarized the safety profile of VDZ for patients with IBD with active or latent TB infection . (bvsalud.org)
  • Prior to 2018, several pro-haemostatic agents such as prothrombin complex concentrate (PCC) were used for the management of factor Xa inhibition-related bleeding. (medthority.com)
  • Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents? (muni.cz)
  • South African Girdwood strain was recovered in 1963 from the vesicle fluid of skin lesions taken from a 45-year-old woman with acute rash-arthritis ( 13 ), and Chinese YN87448 strain was isolated from the serum of a febrile patient in 1992 ( 14 ). (cdc.gov)
  • Anemia and its resulting symptoms like fatigue have a great impact on the quality of life (QoL) of patients suffering from cancer. (springermedizin.at)
  • Hospitals with concerns about a patient with compatible symptoms and potential epidemiologic risk factors should contact their STLT public health officials [PDF - 2 pages] as soon as possible for consultation to determine if ebolavirus testing is indicated. (cdc.gov)
  • 72 hours after the patient first developed symptoms. (cdc.gov)
  • In genetically susceptible individuals, these interactions can lead the patient with asthma to symptoms of breathlessness, wheezing, cough, and chest tightness. (medscape.com)
  • After DAB/IL2 administration, 16.7% of the 60 patients had partial responses, 5% stable disease and 15% mixed responses. (biomedcentral.com)
  • Importantly, 45.5% of the chemo/immuno-naïve sub-population (11/60 patients) experienced partial responses. (biomedcentral.com)
  • Anticoagulants and antiplatelet agents are used for a variety of conditions, including deep venous thrombosis, atrial fibrillation, pulmonary embolism and coronary artery disease. (jefferson.edu)
  • Atrial flutter in an unstable patient should be treated immediately with synchronized cardioversion. (medscape.com)
  • For patient education information, see the Heart Health Center , as well as Atrial Flutter , Arrhythmias (Heart Rhythm Disorders) , Stroke , Supraventricular Tachycardia (SVT, PSVT) , and Palpitations . (medscape.com)
  • It is unknown if this affects neurological outcome for this patient group. (bmj.com)
  • We decided to embark on this project because we realize there is no pre-existing patient-reported outcome (PRO) instrument that truly captures the patient experience of patients who are undergoing these therapies for their vision threatening eye disease. (ophthalmologytimes.com)
  • However, the standard MRI contrast agents currently available contain the heavy metal gadolinium, which when used in patients with impaired kidney function can increase the risk of the serious and potentially fatal condition, Nephrogenic Systemic Fibrosis (NSF). (pharmasalmanac.com)
  • Methanol: systemic agent. (medlineplus.gov)
  • For those patients suffering acute traumatic brain injury the authors could find no studies that investigated the issue of pretreatment with defasciculating doses of competitive neuromuscular blockers and their effect on ICP in patients given SCH. (bmj.com)
  • There is level 2 evidence that SCH caused an increase in ICP for patients undergoing neurosurgery for brain tumours with elective anaesthesia and that pretreatment with defasciculating doses of neuromuscular blockers reduced such increases. (bmj.com)
  • Boston, MA - Kyruus , a leader in provider search and scheduling solutions for health systems, today announced a collaboration with IBM to integrate IBM's Watson Virtual Agent with Kyruus ProviderMatch's smart search and appointment booking capabilities. (masstlc.org)
  • Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. (masstlc.org)
  • Hanslips proved to be a most patient and available search agent. (hanslips.com)
  • Most of the nerve agents were originally synthesized in a search for insecticides, but because of their toxicity, they were evaluated for military use. (cdc.gov)
  • Consequently, these tracers are now applied in our hospital to amend the diagnostics of cancer patients facing the limitations of standard examinations. (snmjournals.org)
  • FAPI PET/CT is a new diagnostic method in imaging cancer patients. (snmjournals.org)
  • Orviglance aims to give cancer patients with poor kidney function access to safe and effective liver imaging to live longer and healthier lives. (pharmasalmanac.com)
  • Latent tuberculosis infection (LTBI) diagnosis in immune-mediated inflammatory diseases is complex because of the patient characteristics and the imperfection of available tests [ 1 ]. (ersjournals.com)
  • Clinicians with concerns about an ebolavirus infection in a patient should contact their state, tribal, local, or territorial (STLT) health department immediately. (cdc.gov)
  • The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report. (bvsalud.org)
  • However, latent TB infection reactivation may still occur, and the ideal therapeutic strategy for patients with inflammatory bowel disease (IBD) who develop active TB infection has not been established. (bvsalud.org)
  • However, its safety in patients with latent TB infection reactivation associated with anti- TNF-alpha agents remains unknown. (bvsalud.org)
  • We designed a prospective study to evaluate the incidence of postoperative bleeding complications in patients taking aspirin, warfarin, or nonsteroidal antiinflammatory agents. (psu.edu)
  • There was no statistically significant difference in postoperative bleeding complications between patients on aspirin, warfarin, or nonsteroidal antiinflammatory agents, when compared with controls. (psu.edu)
  • It may not be necessary to discontinue aspirin, warfarin, or nonsteroidal antiinflammatory agents in patients undergoing many common dermatologic surgical procedures, such as Mohs surgery. (psu.edu)
  • We then correlate identified perception failures of CAs to potential scenarios that might compromise patient safety. (whiterose.ac.uk)
  • We made the hypothesis that the proportion of "bad" responders to mitogen among patients with negative QFT could be underestimated, especially during immunosuppressive drug intake. (ersjournals.com)
  • Gram-negative bacteria were the major pathogens involved in SBP in the cirrhotic patients. (biomedcentral.com)
  • Timely identification of other more likely pathogens and access to routine laboratory testing, such as blood counts and chemistries, is essential for providing appropriate patient care. (cdc.gov)
  • In conclusion, there were high levels of inappropriate use of antibiotics in COVID-19 patients in Sierra Leone. (who.int)
  • In our cohort, results for QFT were found to be positive in 12.2% patients, negative in 82.5% patients and indeterminate in 5.3% patients. (ersjournals.com)
  • La Vacuna Adsorbida Antidiftérica, Antitetánica y la contra la tos Ferina en la forma suministrada por el Serum Institute of India Pvt. (who.int)
  • However, there was a higher rate of patients achieving BASDAI-50 than reported by other investigators. (centerforbiosimilars.com)
  • On behalf of the entire Ascelia Pharma team, I would like to thank patients, investigators, and other collaborators who have been involved in SPARKLE. (pharmasalmanac.com)
  • Patients tested with QFT in the immunology laboratory of the University Hospital of Toulouse, France, between August 2015 and August 2016 were retrospectively enrolled. (ersjournals.com)
  • First, the reported prevalence of indeterminate results is higher in patients (up to 29% [ 4 ]) than in healthy people (1.5%) [ 5 ]. (ersjournals.com)
  • The patient should be treated with an intravenous (IV) sedative prior to cardioversion if their condition permits. (medscape.com)
  • The intravenous anti- TNF-alpha agent administration with an immunomodulator was initiated. (bvsalud.org)